Originator companies are concurrently deploying lifecycle management strategies, advancing next-generation dual and triple agonists, and expanding oral and long-acting formulations to sustain market leadership
"We're trying to make it as easy as possible for patients and providers to get a snapshot of what's available, what's not, and do that in the fastest way," Ro co-founder and CEO Zachariah Reitano told CNBC in an interview
It builds on PRP (platelet-rich plasma) but takes it a step furtherby introducing a gel-like component, it becomes an injectable substance that can add volume to areas like nasolabial folds and under the eyes
The role of metformin in controlling oxidative stress in muscle of diabetic rats
Something in the spice fenugreek seemed to boost GLP-1 signaling in a test tube, but there are no human studies, and it didnt even work in mice